Fragment-based discovery of a new family of non-peptidic small-molecule cyclophilin inhibitors with potent antiviral activities.

Abdelhakim AHMED-BELKACEM, L Colliandre, Nazim AHNOU, Quentin NEVERS, M Gelin, Y Bessin, Rozenn BRILLET, O Cala, D Douguet, W Bourguet, I Krimm, Jean-Michel PAWLOTSKY, JF Guichou,

Nat Commun. 22/09/2016;7 : 12777 10.1038/ncomms12777.

Fragment-based discovery of a new family of non-peptidic small-molecule cyclophilin inhibitors with potent antiviral activities.

L Colliandre, Nazim AHNOU, Quentin NEVERS, M Gelin, Y Bessin, Rozenn BRILLET, O Cala, D Douguet, W Bourguet, I Krimm, Jean-Michel PAWLOTSKY, JF Guichou, Abdelhakim AHMED-BELKACEM,

Nat Commun. 22/09/2016;7 : 12777 10.1038/ncomms12777.

Recent advances in understanding and diagnosing hepatitis B virus infection.

Slim FOURATI, Jean-Michel PAWLOTSKY,

F1000Res. 06/09/2016;5 : REV-2243 10.12688/f1000research.8983.1

Clinical value of on-treatment HCV RNA levels during different sofosbuvir-based antiviral regimens.

B Maasoumy, J Vermehren, MW Welker, B Bremer, D Perner, C Honer Zu Siederdissen, K Deterding, P Lehmann, G Cloherty, B Reinhardt, Jean-Michel PAWLOTSKY, MP Manns, S Zeuzem, M Cornberg, H Wedemeyer, C Sarrazin,

J Hepatol. 01/09/2016;65(3) : 473-482 10.1016/j.jhep.2016.04.006. 13/04/2016

Ombitasvir, paritaprevir, and ritonavir plus ribavirin in adults with hepatitis C virus genotype 4 infection and cirrhosis (AGATE-I): a multicentre, phase 3, randomised open-label trial.

T Asselah, Christophe HEZODE, RB Qaqish, M ElKhashab, T Hassanein, G Papatheodoridis, JJ Feld, C Moreno, S Zeuzem, P Ferenci, Y Yu, R Redman, T Pilot-Matias, N Mobashery,

Lencet Gastroenterol Hepatol. 01/09/2016;1(1) : 25-35 10.1016/S2468-1253(16)30001-2. 16/06/2016

Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study.

LS Belli, M Berenguer, PA Cortesi, M Strazzabosco, SR Rockenschaub, S Martini, C Morelli, F Donato, R Volpes, GP Pageaux, S Fagiuoli, Giuliana AMADDEO, G Perricone, C Vinaixa, G Berlakovich, R Facchetti, W Polak, C Duvoux,

J Hepatol. 01/09/2016;65(3) : 524-531 10.1016/j.jhep.2016.05.010 17/05/2016

Primary Tumor Versus Liver-First Strategy in Patients with Stage IVA Colorectal Cancer: A Propensity Score Analysis of Long-term Outcomes and Recurrence Pattern

C Lim, A Doussot, M Osseis, C Salloum, C Gomez Gavara, P Compagnon, F Brunetti, Julien CALDERARO, D Azoulay,

Ann Surg Oncol 01/09/2016;23(9) : 3024-3032 10.1245/s10434-016-5265-5 12/05/2016

A randomized, controlled study of peginterferon lambda-1a/ribavirin ± daclatasvir for hepatitis C virus genotype 2 or 3.

GR Foster, K Chayama, WL Chuang, H Fainboim, M Farkkila, A Gadano, GB Gaeta, Christophe HEZODE, Y Inada, J Heo, H Kumada, SN Lu, P Marcellin, C Moreno, SK Roberts, SI Strasser, AJ Thompson, J Toyota, SW Paik, JM Vierling, AL Zignego, D Cohen, F McPhee, M Wind-Rotolo, S Srinivasan, M Hruska, H Myler, SD Portsmouth,

Springerplus. 19/08/2016;5(1) : 1365 10.1186/s40064-016-2920-z.

Duplicate inferior vena cava in liver transplantation: A note of caution when left renal vein ligation is needed

M Osseis, C Lim, C Salloum, G Boustany, A Doussot, E Lahat, CG Gavara, P Compagnon, Alain LUCIANI, D Azoulay,

Liver Transpl. 01/08/2016;22(8) : 1159-1161 10.1002/lt.24477 11/07/2016

Automated quantification of Epstein-Barr Virus in whole blood of hematopoietic stem cell transplant patients using the Abbott m2000 system.

M Salmona, Slim FOURATI, L Feghoul, C Scieux, A Thiriez, F Simon, M Resche-Rigon, J LeGoff,

Diagn Microbiol Infect Dis. 01/08/2016;85(4) : 428-32 10.1016/j.diagmicrobio.2016.04.017. 28/04/2016